IFS has been shown to reduce pain and depression and improve physical function for people with rheumatoid arthritis. A study by a team at Harvard Medical School, led by Dr Nancy Chadic, has concluded that “IFS is feasible and acceptable for patients with rheumatoid arthritis.”
IFS therapy has been accepted as an evidence-based practice in the US and is listed on the federal NREPP (National Registry for Evidence-based Programs and Practices) website, NREPP.SAMHSA.gov. As a clinical treatment, the site rates IFS as effective for improving general functioning and well-being. It’s also been rated as promising for improving: physical health conditions and symptoms; phobia, panic and generalized anxiety disorders and symptoms; personal resilience; and depression.
The listing of IFS on NREPP – and the research that led to that listing – affirm the huge potential of IFS therapy for advancing emotional healing and mental well-being.